Feature Stories

Featured Stories

View all stories

• 
  A back-to-school makeover for Wichita crosswalks
  Jul 25, 2019 -- Schoolchildren and other pedestrians will tread a little more safely this fall thanks to a volunteer effort spearheaded by a research assistant at the University of Kansas School of Medicine-Wichita.
• 
  KUSM-W and Project ADAM provide tools, system to prevent sudden cardiac deaths at schools
  Jul 25, 2019 -- Project ADAM (Automated Defibrillators in Adam’s Memory) began in 1999 in Wisconsin after 17-year-old Adam Lemel collapsed and died while playing basketball.
• 
  Burnout common in med school and residency, KU study finds, but so is combatting it
  Jun 20, 2019 -- Multi-pronged approaches to burnout and wellness are underway, building off the belief physicians must take good care of their own health to properly care for patients.
• 
  $1.8M grant will help doctors combat increasing mental illness among children
  Jun 20, 2019 -- The grant, awarded by the U.S. Department of Health and Human Services, will be used in collaboration by the KU School of Medicine-Wichita departments of pediatrics and psychiatry & behavioral sciences, Kansas Department of Health and Environment, Kansas Department for Aging and Disability Services, and KU Center for Public Partnerships & Research.
• 
  John Dorsch's efforts to ensure rural Kansas has doctors will continue after retirement
  May 30, 2019 -- Dr. Dorsch is retiring after 20 years overseeing KU School of Medicine-Wichita programs that provide medical students a taste of rural practice.
• 
  KU School of Medicine celebrates Class of 2019 at graduation
  May 17, 2019 -- Of the 309 students who graduated from the School of Medicine's campuses in Kansas City, Wichita and Salina, 207 received MDs and 102 students received master's and doctoral degrees in programs such as public health, microbiology, health services administration and neuroscience.
• 
  KUSM-W faculty are key to development of groundbreaking drug esketamine
  Apr 25, 2019 -- The drug, called esketamine, is being marketed as a nasal spray under the name Spravato. Approved for use by the FDA in March, esketamine has been shown to help a significant percentage of people who don’t respond to existing antidepressants.
• 
  Schwartz Rounds let providers share stories, feelings of compassionate care
  Apr 25, 2019 -- The new bimonthly program promotes wellness among doctors, nurses and other caregivers.
• 
  KU School of Medicine students announce where they will be residents
  Mar 18, 2019 -- On the third Friday in March, more than 30,000 medical students across the country find out which residency program they've been matched to.
• 
  Marsh scholarships help students at three colleges
  Mar 04, 2019 -- Most parents look forward to the day when they can stop helping pay for their children’s college education. Connie Marsh, M.D., took a different view as her three children completed their college years.